1.Valved Conduit with Glutaraldehyde-Fixed Bovine Pericardium Treated by Anticalcification Protocol.
Hong Gook LIM ; Gi Beom KIM ; Saeromi JEONG ; Yong Jin KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2014;47(4):333-343
BACKGROUND: A preclinical study was conducted for evaluating a valved conduit manufactured with a glutaraldehyde (GA)-fixed bovine pericardium treated using an anticalcification protocol. METHODS: Bovine pericardia were decellularized, fixed with GA in an organic solvent, and detoxified. We prepared a valved conduit using these bovine pericardia and a specially designed mold. The valved conduit was placed under in vitro circulation by using a mock circulation model, and the durability under mechanical stress was evaluated for 2 months. The valved conduit was implanted into the right ventricular outflow tract of a goat, and the hemodynamic, radiologic, histopathologic, and biochemical results were obtained for 6 months after the implantation. RESULTS: The in vitro mock circulation demonstrated that valve motion was good and that the valved conduit had good gross and microscopic findings. The evaluation of echocardiography and cardiac catheterization demonstrated the good hemodynamic status and function of the pulmonary xenograft valve 6 months after the implantation. According to specimen radiography and a histopathologic examination, the durability of the xenografts was well preserved without calcification at 6 months after the implantation. The calcium and inorganic phosphorus concentrations of the explanted xenografts were low at 6 months after the implantation. CONCLUSION: This study demonstrated that our synergistic employment of multiple anticalcification therapies has promising safety and efficacy in the future clinical study.
Biocompatible Materials
;
Bioengineering
;
Bioprosthesis
;
Calcium
;
Cardiac Catheterization
;
Cardiac Catheters
;
Echocardiography
;
Employment
;
Fungi
;
Glutaral
;
Goats
;
Heart Valves
;
Hemodynamics
;
Heterografts
;
Pericardium*
;
Phosphorus
;
Radiography
;
Stress, Mechanical
2.Biological Property of Recombinant Hemagglutinin-Neuraminidase Protein of Avian Paramyxovirus Type 6 Expressed by Recombinant Baculovirus.
Ji Ye KIM ; Hyun Jeong LEE ; Soo Jeong KYE ; Saeromi KIM ; Hee Jung SEUL ; Sang Eun KIM ; Hee Soo LEE ; Suk Chan JUNG ; Kang Seuk CHOI
Journal of Bacteriology and Virology 2015;45(4):319-327
Hemagglutination inhibition (HI) test employing whole virus antigen is a prescribed serological test for serotyping, diagnosis and surveillance for avian paramyxoviruses (APMVs). For use as alternative to the virus antigen, hemagglutinin-neuraminidase (HN) protein gene of the wild duck isolate APMV-6/WB12-163FS of APMV serotype 6 (APMV-6) was amplified, cloned and expressed in Spodoptera frugiperda insect cells. The HN gene of 1,842 bps in length showed nucleotide and amino acid homology of 93.4% and 97.1%, respectively with that of APMV-6 prototype strain. Putative sialic acid binding motif and potential N-linked glycosylation sites were conserved. In Western blot analysis, the expressed protein had a molecular mass of 66 kDa and reacted specifically with antiserum to APMV-6. In addition, the recombinant HN protein showed biological properties such as hemagglutination (HA) and elution. The recombinant HN protein produced from infected cells showed high HA titers (approximately 2(13) HA unit/ml). The HA activity of the recombinant HN protein was inhibited by antisera to APMV-6. In cross HA inhibition test, the recombinant HN protein had the highest titers with antisera to homologous APMV serotype, although there was weak cross reaction with some of antisera to other APMV serotypes. Our results indicated that recombinant APMV-6 HN protein would have the potential as alternative to the APMV-6 antigen in HI assays.
Avulavirus*
;
Baculoviridae*
;
Blotting, Western
;
Clone Cells
;
Cross Reactions
;
Diagnosis
;
Ducks
;
Glycosylation
;
Hemagglutination
;
HN Protein
;
Immune Sera
;
Insects
;
N-Acetylneuraminic Acid
;
Serologic Tests
;
Serotyping
;
Spodoptera
3.Preparation and diagnostic utility of a hemagglutination inhibition test antigen derived from the baculovirus-expressed hemagglutinin-neuraminidase protein gene of Newcastle disease virus.
Kang Seuk CHOI ; Soo Jeong KYE ; Woo Jin JEON ; Mi Ja PARK ; Saeromi KIM ; Hee Jung SEUL ; Jun Hun KWON
Journal of Veterinary Science 2013;14(3):291-297
A recombinant hemagglutinin-neuraminidase (rHN) protein from Newcastle disease virus (NDV) with hemagglutination (HA) activity was expressed in Spodoptera frugiperda cells using a baculovirus expression system. The rHN protein extracted from infected cells was used as an antigen in a hemagglutination inhibition (HI) test for the detection and titration of NDV-specific antibodies present in chicken sera. The rHN antigen produced high HA titers of 2(13) per 25 microL, which were similar to those of the NDV antigen produced using chicken eggs, and it remained stable without significant loss of the HA activity for at least 12 weeks at 4degrees C. The rHN-based HI assay specifically detected NDV antibodies, but not the sera of other avian pathogens, with a specificity and sensitivity of 100% and 98.0%, respectively, in known positive and negative chicken sera (n = 430). Compared with an NDV-based HI assay, the rHN-based HI assay had a relative sensitivity and specificity of 96.1% and 95.5%, respectively, when applied to field chicken sera. The HI titers of the rHN-based HI assay were highly correlated with those in an NDV-based HI assay (r = 0.927). Overall, these results indicate that rHN protein provides a useful alternative to NDV antigen in HI assays.
Animals
;
Antibodies, Viral/*blood
;
Antigens, Viral/*diagnostic use/genetics/metabolism
;
Baculoviridae/genetics
;
Chickens
;
HN Protein/*diagnostic use/genetics/metabolism
;
Hemagglutination Inhibition Tests/*methods/veterinary
;
Newcastle Disease/*diagnosis/immunology/virology
;
Newcastle disease virus/genetics/*immunology/metabolism
;
Poultry Diseases/*diagnosis/immunology/virology
;
Recombinant Proteins/diagnostic use/genetics/metabolism
;
Sf9 Cells
;
Spodoptera
4.Generation and Biological Characterization of a Neutralization-Resistant Mutant of Newcastle Disease Virus.
Mi Ja PARK ; Soo Jeong KYE ; Ji Ye KIM ; Saeromi KIM ; Hee Jung SEUL ; Choi Kyu PARK ; Kang Seuk CHOI
Journal of Bacteriology and Virology 2012;42(4):330-338
A neutralization-resistant mutant of Newcastle disease virus (NDV) Kr005 strain belonging to class II genotype VII was generated using a neutralizing monoclonal antibody and its biological effects were assessed. The mutant showed single amino acid substitution (E to K) at position 347 of the hemagglutinin-neuraminidase (HN) protein (E347K mutant). The E347K mutant exhibited marked rounding of the cells and few syncytia in infected chicken embryofibroblast (CEF) cells. The hemadsorption and neuraminidase activities of the E347K mutant of the wild-type virus were 118% and 166%, respectively. The mutant produced a rapid elution pattern whereas the wild type had a slow elution pattern. Growth kinetics studies showed that the E347K mutant produced an 80-times higher yield of extracellular virus in CEF cells compared with the wild-type virus. The time-course virus titer showed a marked increase in mutant-infected cells from 6 h to 12 h post infection (pi), which was consistent with the titer pattern time-course for NA activity. The E347K mutant virus showed a slight decrease in virulence compared to the wild-type virus, but there was no change in pathotype when measured by in vivo pathogenicity testing. These results suggest that an E347K mutation in HN protein might be associated with increased NA activity and subsequent enhancement of virus release from infected cells without change in viral pathotype.
Amino Acid Substitution
;
Animals
;
Chickens
;
Genotype
;
Giant Cells
;
Hemadsorption
;
HN Protein
;
Kinetics
;
Neuraminidase
;
Newcastle Disease
;
Newcastle disease virus
;
Sprains and Strains
;
Viral Load
;
Virus Release
;
Viruses
5. Quantitative autonomic function test in differentiation of multiple system atrophy from idiopathic Parkinson disease
Ji-Yun PARK ; Dongseok YANG ; Hei-Jun YANG ; Hyun Ah KIM ; Saeromi KIM ; Deokhyun HEO ; Jeong-Ho PARK ; Eek-Sung LEE ; Tae-Kyeong LEE
Chinese Medical Journal 2019;132(16):1919-1924
Background:
Differential diagnosis of idiopathic Parkinson disease (IPD) and multiple system atrophy-Parkinson type (MSA-P) is challenging since they share clinical features with parkinsonism and autonomic dysfunction. To distinguish MSA-P from IPD when the symptoms are relatively mild, we investigated the usefulness of the quantitative fractionalized autonomic indexes and evaluated the correlations of autonomic test indexes and functional status.
Methods:
Thirty-six patients with parkinsonism (22 with IPD and 14 with MSA-P) in Soonchunhyang University Bucheon Hospital from February 2014 to June 2015 were prospectively enrolled in the study. We compared fractionalized autonomic indexes and composite autonomic scoring scale between patients with IPD and MSA-P with Hoehn and Yahr (H&Y) score ≤3. Parasympathetic indexes included expiratory/inspiratory ratio during deep breathing, Valsalva ratio (VR), and regression slope of systolic blood pressure (BP) in early phase II (vagal baroreflex sensitivity) during Valsalva maneuver. Sympathetic adrenergic indexes were pressure recovery time (PRT) and adrenergic baroreflex sensitivity (BRSa) (BP decrement associated with phase 3 divided by the PRT), sympathetic index 1, sympathetic index 3, early phase II mean BP drop, and pulse pressure reduction rate. Additionally, we compared the unified multiple system atrophy rating scale (UMSARS) and H&Y scores and the autonomic indexes in all patients.
Results:
PRT was significantly different between the IPD and MSA-P groups (